Amgen Announces Positive Top-Line Results From Phase 3 TESLA Trial Of Evolocumab (AMG 145) In Patients With Homozygous Familial Hypercholesterolemia Read more about Amgen Announces Positive Top-Line Results From Phase 3 TESLA Trial Of Evolocumab (AMG 145) In Patients With Homozygous Familial Hypercholesterolemia
Amgen's Talimogene Laherparepvec Reduced Size Of Melanoma Tumors In New Phase 3 Retrospective Analysis Read more about Amgen's Talimogene Laherparepvec Reduced Size Of Melanoma Tumors In New Phase 3 Retrospective Analysis
Amgen Names David Piacquad Senior Vice President, Business Development Read more about Amgen Names David Piacquad Senior Vice President, Business Development
Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation Read more about Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation
Amgen Announces 2014 Second Quarter Dividend Read more about Amgen Announces 2014 Second Quarter Dividend
Amgen To Present At The Cowen And Company 34th Annual Healthcare Conference Read more about Amgen To Present At The Cowen And Company 34th Annual Healthcare Conference
Amgen To Present At The RBC Capital Markets' Global Healthcare Conference Read more about Amgen To Present At The RBC Capital Markets' Global Healthcare Conference
Amgen And Merck Announce Collaboration To Evaluate Investigational Combination Treatment For Advanced Melanoma Read more about Amgen And Merck Announce Collaboration To Evaluate Investigational Combination Treatment For Advanced Melanoma
Amgen Announces Positive Top-Line Results From Phase 3 RUTHERFORD-2 Trial Of Evolocumab (AMG 145) In Patients With Heterozygous Familial Hypercholesterolemia Read more about Amgen Announces Positive Top-Line Results From Phase 3 RUTHERFORD-2 Trial Of Evolocumab (AMG 145) In Patients With Heterozygous Familial Hypercholesterolemia
Amgen Announces Positive Top-Line Results From Phase 3 LAPLACE-2 Trial Of Evolocumab (AMG 145) In Combination With Statins In Patients With High Cholesterol Read more about Amgen Announces Positive Top-Line Results From Phase 3 LAPLACE-2 Trial Of Evolocumab (AMG 145) In Combination With Statins In Patients With High Cholesterol
